Geron Corporation (GERN)

NASDAQ: GERN · Real-Time Price · USD

1.400

+0.020 (1.45%)

At close: Sep 5, 2025, 4:00 PM

1.400

0.00 (0.00%)

Pre-market: Sep 8, 2025, 8:45 AM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Therapeutic Products for Oncology	76.99M	Log In	Log In	Log In	Log In	Upgrade
Therapeutic Products for Oncology Growth	32386.92%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	76.99M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	32386.92%	Log In	Log In	Log In	Log In	Upgrade